Detected ·

Slate Medicines

$245M—

Slate Medicines announced a definitive agreement to combine with Fulcrum Therapeutics in an all-stock transaction, alongside an oversubscribed $245M private financing led by Frazier Life Sciences. The combined company will focus on next-generation therapeutics for migraine and headache disorders, with lead program SLTE-1009 advancing through clinical stages.

Amount
$245 000 000 USD
Stage
—
Event
Funding round
Detected
2026-08-17 12:05:11 UTC
Signal ID
27f007e8-eccf-46d8-b0b0-47da6c58a850

As the API returns it

{
  "id": "27f007e8-eccf-46d8-b0b0-47da6c58a850",
  "created_at": "2026-08-17T12:05:11.007451Z",
  "company_name": "Slate Medicines",
  "company_website_url": "www.slatemedicines.com",
  "company_linkedin_url": "https://www.linkedin.com/company/slate-medicines",
  "event_type": "funding",
  "funding_amount": 245000000,
  "funding_currency": "USD",
  "funding_stage": null,
  "message": "*Slate Medicines announced a definitive agreement to combine with Fulcrum Therapeutics in an all-stock transaction, alongside an oversubscribed $245M private financing led by Frazier Life Sciences. The combined company will focus on next-generation therapeutics for migraine and headache disorders, with lead program SLTE-1009 advancing through clinical stages.*"
}

Latest rounds

FLEXECHARGE——LinkedIn
Nimesis Technology€550KOtherLinkedIn
Remanence$30MSeedLinkedIn
Noeri$110M—LinkedIn
Nimesis Technology——Site / LinkedIn
Nomadic Drones$6MSeedSite / LinkedIn
ODAIA—Series CLinkedIn
Remanence$30MSeedLinkedIn
Model ML$250MSeries BLinkedIn
Commit Biologics$60MSeedLinkedIn
Treat Health€3MPre-SeedLinkedIn
Tiberius Aerospace$85MSeries ASite / LinkedIn
Numa$45MSeries CLinkedIn
ODAIA—Series CSite / LinkedIn
Pulpex£24.6MSeries DSite / LinkedIn
Q-CTRL$290MSeries CLinkedIn
Arva AI$20MSeries ALinkedIn
Arva AI$20MSeries ASite / LinkedIn
Fairly$22.4MSeries ASite / LinkedIn
Previsia€3.8MSeedSite / LinkedIn
August AI$12M—Site / LinkedIn
MountAIn€7.3M—Site / LinkedIn
Treat Health€3M—Site / LinkedIn
Gotham FC$100MOtherSite / LinkedIn
Isomorphic Labs$5B—Site / LinkedIn
End Close$3.5MSeed—
Model ML$250MSeries BSite / LinkedIn
Remanence$30M——
Remanence$30M——
Hadl.ai——LinkedIn
Remanence€27.2MSeed—
Bricks Performance SystemDKK 1.5M—Site / LinkedIn
Noeri$110M——
Remedy Robotics$62MOtherLinkedIn
COUNT$6.5MSeedSite / LinkedIn
Nimble Science—AngelSite / LinkedIn
Corma$125MSeries A—
Bedrock Energy$24M—LinkedIn
Corma$125MSeries ALinkedIn
ComeHome—OtherSite / LinkedIn
Queens Court Capital——Site / LinkedIn
FLEXECHARGE——Site / LinkedIn
Numa$45MSeries CLinkedIn
The Vaccine Group (TVG)£500KOtherSite / LinkedIn
AgentWeb—Other—
Corma$125MSeries ALinkedIn
Geminus—Other—
Drogue—Pre-SeedSite / LinkedIn
Traitomic€20M—LinkedIn
Centese——Site / LinkedIn